The reopening of the Chinese economy after the pandemic could present investment opportunities for those interested in the Chinese market.
Tag: investment
MTQ Corporation (SGX:M05) – Promising Business Turnaround Potential with Strong Financial Performance
MTQ Corporation SGX:M05 presents an attractive investment opportunity with its strong financials and potential for business turnaround.
Wabash National Corporation (WNC:NYSE) – Driving Growth with Strong Financial Performance and a Solid Order Book
With an attractive valuation, positive financial outlook, and commitment to innovation, Wabash National $WNC is positioned for success.
Regis Corporation (NYSE:RGS) – Why I Remain Optimistic On Its Turnaround
Why I remain optimistic on Regis Corporation's ($RGS) successful turnaround through cost-cutting, and growth initiatives under new management.
Haw Par Group (SGX:H02) – A Simple Analysis II
I covered Haw Par Group back in 2019. Hence I think it is time to revisit this company which is trading at multi year lows.
2022 Portfolio Review -A Quick Look Back, Then Start Looking Forward
My annual investment review for 2022. This year has been a rollercoaster for the stock market, here are the key takeaways from my portfolio.
uniQure NV (NASDAQ:QURE) – A Prognosis
We study uniQure NV ($QURE), a biotechnology company focused on developing gene therapies for rare diseases.
VolitionRx Limited (NYSE: VNRX) – Enters Commercial Stage for Nu.Q Vet Cancer Test
VolitionRx is commercially introducing a product with a huge addressable market. If successful, the market will rerate the stock.
uniQure N.V. (NASDAQ:QURE) – World’s Most Expensive Medicine
uniQure's AMT-061 is currently the world's most expensive drug. Here's why investing in $QURE may be rewarded with strong returns.
Book Review: Insider Buy Superstocks by Jesse Stine
Here is my summary and review of "Insider Buy Superstocks". It has some important concepts to achieve great investment returns.